Zobrazeno 1 - 5
of 5
pro vyhledávání: '"E V Loftus Jr."'
Autor:
M C Dubinsky, G D’Haens, O Dewit, P Juillerat, R Panaccione, T Fujii, A P Lacerda, E Dubcenco, S Anyanwu, C Doshi, M Mallick, A Garrison, J Liu, E V Loftus Jr
Publikováno v:
Journal of Crohn's and Colitis. 17:i104-i106
Background Corticosteroids (CS) may be used for induction of remission in Crohn’s disease (CD); however, side effects, toxicities, and low rates of mucosal healing may limit their long-term use. Safety and efficacy of upadacitinib (UPA), an oral se
Autor:
L Peyrin-Biroulet, P Bossuyt, D Bettenworth, E V Loftus Jr., S Anjie, G D’Haens, M Saruta, P Arkkila, D H Kim, D Choi, W Reinisch
Publikováno v:
Journal of Crohn's and Colitis. 17:i574-i576
Background Network meta-analysis (NMA) using randomised controlled trial (RCT) data can provide indirect evidence on comparative efficacy of various treatments.1 The NMA reported herein was conducted to evaluate infliximab (IFX) and vedolizumab (VDZ)
Autor:
R M Q Khan, A N Ananthakrishnan, E V Loftus Jr, U Iroku, R Mukherjee, S Uddin, F D Odufalu, J Liu
Publikováno v:
Journal of Crohn's and Colitis. 17:i977-i979
Background The incidence of inflammatory bowel disease (IBD) has risen among Black individuals and Hispanic or Latino individuals in the USA in recent decades; however, these patients are underrepresented in clinical trials of IBD therapies. We aimed
Publikováno v:
Journal of Crohn's and Colitis. 17:i568-i569
Background Patients with Crohn’s disease (CD) experience reduced quality of life (QoL), and disease-related impact on work productivity, contributing to a high disease burden. This study evaluated the association of achieving endoscopic outcomes at
Publikováno v:
Journal of Crohn's and Colitis. 17:i919-i920
Background STRIDE-II guidelines recommend endoscopic healing as an important treatment goal in Crohn’s disease (CD). This study evaluated the association of achieving endoscopic outcomes at week 12 and clinical outcomes at week 52 of maintenance tr